Permissive Cardiotoxicity: Real World Outcomes of CAR-T Therapy in Patients with Heart Failure and Reduced Ejection Fraction

Key Points

• Cardiotoxicity rates increased, with significant implications for heart failure management and patient care,
• The study reports a 40% incidence of cardiotoxicity related to CAR-T therapy in heart failure patients,
• Observational analysis of real-world outcomes across multiple facilities highlights varied responses to treatment,
• Findings may enable better monitoring strategies and tailored interventions for heart failure patients under CAR-T therapy.